Protein Binder
A class of proteins capable of binding target molecules with high affinity and specificity, including antibodies, antibody fragments, designed repeat proteins and de novo designed small proteins. They exert blocking effects by occupying target binding sites or through steric hindrance, do not depend on animal immunization, are easily expressed, have good stability and can be lyophilized for storage.
Timeline (last 90 days)
The core challenge of designing protein binding agents lies in simultaneously satisfying shape complementarity, electrostatic complementarity, and hydrophobic matching with the target surface while also ensuring stable folding of the binder itself.
Compared with traditional antibodies (about 150 kDa), small binding agents (such as antibody mimetics, affibodies, or designed ankyrin repeat proteins) typically have molecular weights of only a few to a dozen-plus kDa, offering better tissue penetration and lower manufacturing costs.
Protein binders are a class of proteins that can bind target molecules with high affinity and high specificity, with typical representatives including antibodies, antibody fragments (such as scFv and Fab), designed repeat proteins (such as DARPins and affibody), and de novo designed small proteins (de novo minibinder).
The practical application of protein binders still requires experimental verification of their affinity, stability, and safety.
The mechanism of action of protein binders is to prevent the toxin from binding to ion channels by occupying receptor binding sites on the toxin's surface or through steric hindrance, rather than directly chemically neutralizing the toxin.
Anthropic's model Claude successfully designed a protein binder targeting scorpion neurotoxins.
Unlike earlier methods that required large numbers of homologous sequence alignments, modern protein language models can directly predict structure from a single sequence, or even generate new sequences with specific functions from scratch.
All Facts (7)
Compared with traditional antibodies (about 150 kDa), small binding agents (such as antibody mimetics, affibodies, or designed ankyrin repeat proteins) typically have molecular weights of only a few to a dozen-plus kDa, offering better tissue penetration and lower manufacturing costs.
50%UnverifiedThe core challenge of designing protein binding agents lies in simultaneously satisfying shape complementarity, electrostatic complementarity, and hydrophobic matching with the target surface while also ensuring stable folding of the binder itself.
50%UnverifiedThe practical application of protein binders still requires experimental verification of their affinity, stability, and safety.
50%UnverifiedThe mechanism of action of protein binders is to prevent the toxin from binding to ion channels by occupying receptor binding sites on the toxin's surface or through steric hindrance, rather than directly chemically neutralizing the toxin.
50%UnverifiedProtein binders are a class of proteins that can bind target molecules with high affinity and high specificity, with typical representatives including antibodies, antibody fragments (such as scFv and Fab), designed repeat proteins (such as DARPins and affibody), and de novo designed small proteins (de novo minibinder).
50%UnverifiedUnlike earlier methods that required large numbers of homologous sequence alignments, modern protein language models can directly predict structure from a single sequence, or even generate new sequences with specific functions from scratch.
50%UnverifiedAnthropic's model Claude successfully designed a protein binder targeting scorpion neurotoxins.
50%